SPICE III

  • Research type

    Research Study

  • Full title

    Early Goal Directed Sedation Compared with Standard Care in Mechanically Ventilated Patients in Intensive Care

  • IRAS ID

    164410

  • Contact name

    Matt Wise

  • Contact email

    mattwise@doctors.org.uk

  • Sponsor organisation

    Australia and New Zealand Intensive Care (ANZIC)- Research Centre

  • Clinicaltrials.gov Identifier

    NCT01728558

  • Duration of Study in the UK

    3 years, 1 months, 30 days

  • Research summary

    Sedation Practices in Intensive Care Evaluation (SPICE).

    The majority of critically ill patients admitted to intensive care require artificial ventilation and this requires the use of sedative drugs. Although the use of sedatives is ubiquitous throughout the world, the choice of which drugs or combination of drugs is optimal is unknown.
    In recent years clinical practice has moved towards lighter levels of sedation when clinically safe, better management of pain and recognition of delirium (sometimes called 'acute confusional state'). Despite this during the early period of ventilation (within 48 hours) deep sedation is common and this correlates with a longer period of ventilation and increased death.
    The current investigation is an international multi-centre study which aims to compare standard sedation protocols with a protocol of early goal directed sedation (titrating drugs to achieve light sedation).

  • REC name

    Wales REC 3

  • REC reference

    14/WA/1205

  • Date of REC Opinion

    20 Nov 2014

  • REC opinion

    Further Information Favourable Opinion